<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: The aim of this study was to determine whether expression of the excision repair cross complementing protein (ERCC1), <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> (GST-p) and thymidylate synthase (TS) predict response in patients with advanced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> treated with <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi>/<z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>METHODOLOGY: The study population consisted of 39 patients with advanced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (median age, 65 years) </plain></SENT>
<SENT sid="2" pm="."><plain>Patients were treated with the modified FOLFOX 6 regimen </plain></SENT>
<SENT sid="3" pm="."><plain>The expression of ERCC-1, GST-p and TS of <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> were examined by immunohistochemistry </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The response rate of modified FOLFOX 6 chemotherapy was 51.3% </plain></SENT>
<SENT sid="5" pm="."><plain>The positive rates of ERCC-1, GST-p and TS were 43.6%, 33.3% and 66.7%, respectively </plain></SENT>
<SENT sid="6" pm="?"><plain>The patients without ERCC-1 (p=0.0248) or GST-p </plain></SENT>
<SENT sid="7" pm="."><plain>(p=0.0019) expression were more likely to respond to chemotherapy </plain></SENT>
<SENT sid="8" pm="."><plain>TS expression did not correlate with chemotherapeutic response </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Immunohistochemical studies for ERCC-1 and GST-p may be useful in prediction of the response to <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi>/<z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> chemotherapy in advanced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
</text></document>